Wednesday 3 ingrid lieten and dominque verté

Office of Ingrid Lieten, Vice-Minister-President of the Government of Flanders Flemish Minister for Innovation, Public Investment, Media and Poverty Reduction

"Historical background

  Innovation policy based on:

- strong scientists

- strong companies

- societal challenges

Ingrid Lieten, Vice-Minister-President of the Government of Flanders and Flemish Minister for Innovation, Public Investment, Media and Poverty Reduction

Grand Societal and Economic Challenges

TRANSFORMATION BY

INNOVATION

ECO-INNOVATION

INNOVATION

IN CARE

SUSTAINABLE MOBILITY AND

LOGISTICS

SOCIAL INNOVATION

Cooperation projects and initiatives

Solid base

Fundamental research, strategic basic research, research infrastructure, HR, eco-system

ENERGY INNOVATION

Innovation Hubs

"

Flanders’ research and innovation policy priorities (1)

Focused innovation strategies

More innovative strength for the economy of Flanders e.g. strengthen and accelerate the valorisation trajectory, more innovative entrepreneurship, facilitate networking, clustering and cooperation means

Flanders as an innovation-friendly top region e.g. increase the innovation potential by investing in human capital, adhere to major innovation trends, a state-of-the-art research infrastructure

Strengthen the fundamentals of science policy e.g. attractive and flexible career paths for researchers, optimisation and fine-tuning of support measures, stimulate R&D and innovation via higher education

Benefits from the research and innovation system through better impact, higher efficiency and increasing resources and R&D budget e.g. pursue budget increases (3% R&D/GDP target), Flanders a fully-fledged partner in

European R&D and innovation area, effective policy evaluation & impact analysis

4

"Policy strategy science &Innovation

Increased funding for innovation

 - 2011 + 65 M. euro.  - + 97 M.euro IWT funding  - grow path for innovation till 2014:  - 2012: + 60 M euro  - 2013: + 62,5 M euro

5 Kabinet Ingrid Lieten, viceminister-president van de Vlaamse Regering en Vlaams minister van Innovatie,

Overheidsinvesteringen, Media en Armoedebestrijding

"

Policy strategy science &Innovation

  Transformational Medical Research programme

  Centre for Medical Innovation (CMI): biobank 5 CRC

  Strategic research centres: (Health &Care) VIB (Biotechnology), IMEC (Nanotechnology) I-minds (ICT) VITO (energy)   SOFI fund (2011: spin offs SOC’s 10 M. Euro, 2012: spin offs

universities 10 M Euro)   Health& care fund GIMV (200 M euro)   Care Innovation Space Flanders (10 M Euro)

6 Kabinet Ingrid Lieten, viceminister-president van de Vlaamse Regering en Vlaams minister van Innovatie, Overheidsinvesteringen, Media en Armoedebestrijding

"

Agency for Innovation by Science and Technology

  Created in 1991 by the Government of Flanders

  External agency with independent board of directors

  Mission is defined by science and innovation law (decree of 30 april 2009)

  Ingrid Lieten, Flemish minister for Innovation, Public investments, Media and Reduction of Poverty

•   Budget 2013 : ca. 335 miljoen euro

•   122 VTE

"

Policy context

Government programme 2009-2014

Policy note on innovation 2009-2014

Policy conceptpaper

innovation

Annual policy paper

& Budget

IWT management contract

Annual businessplan

9

"IWT financial support programmes

R&D enterprise projects & SME-programme & SPRINT

Strategic Basic research

Networks and

intermediaries

R&D organisations

Enterprises

TETRA Agricultur

e

Individual researchers

Innovation grant

Baekeland grant

PhD grant

Collective Innovation Tracks

TBM

"

11

Transformational Medical Research programme

  The Flemish government decided to step in and launch the Transformational Medical Research (TGO) programme:   Accelerate development of more effective, safe

and affordable drugs   Strengthen the Flemish biopharma cluster   Make Flanders an attractive region for

innovative clinical trials   Provide our society with access to the best

therapies   Budget Call 2012-2013: 10 million EUR.

"

Flanders’ research and innovation actors (5) / VIB

•  1995: Virtual institute over: UGent, KULeuven, UA and VUB

•  Biomolecular research in life sciences •  Excellent research •  Active Tech Transfer •  Communication

•  Number of employees: > 1,300 employees (2013); 30% non-Belgian, > 60 nationalities;

•  Budget : 77,1 mn euro (2010), of which 56% Flemish Public funding;

•  Research areas

•  Research service facilities, eg sequencing, protein analysis, imaging, …. •  2 Bio-incubators •  13 Spin-offs

12

•  Bioinformatics •  Cancer •  Cardiovascular

medicine •  Developmental biology •  Inflammation and

immunity •  Microbiology

• Neuroscience • Plant biology • Proteomics • Structural biology • Systems biology

Gimv Health & Care Fund

with Flemish Region as co-sponsor

Leading the path towards a healthy H&C sector

Antwerp, april 2013

P-862

"Care innovation

Focus: elderly care Minister Ingrid Lieten


"1. Background

Belgium = 10th oldest country in the world

Belgium Flemish Region

Brussels-Capital Region

Walloon Region

Total of people aged over 60

22.99% 24.11% 18.44% 22.41%

Total of people aged over 80

4.92% 4.98% 4.58% 4.92%

"1. Background

!

"1. Background

!

"Care Innovation

-   Flanders’ Care: different domains 4 ministers included -   Stimulate systemic transition

-   Development of new and sustainable eco-systems

18 Kabinet Ingrid Lieten, viceminister-president van de Vlaamse Regering en Vlaams minister van Innovatie, Overheidsinvesteringen, Media en Armoedebestrijding

!"#$%&'"()'* +,-+,+.--*

--**

*

*

*

*

*

!"#$%&'()*)&

+,)-(*.(*'()*)/&0.(*1%'()*)&

2(()3(.-4*)5.#6&

7%%$%5*)5$*'()$)-*)&

&&

8,)5*93(.-&

!"#$%3(.-/-*3$)%3(.-&

:(;,,9&<$*)%5*)4*)5.#6&

=>/=>&3(.-&

+(.5?*.@9$AB/4.$%$%(1?,)-&

C*9B3(.-&

D,-?*.3(.-$)-%4*)5.#6&

E.$A'$99$-*.%'*.;&F)56(*5$)-&

G00C&

H#$%,.5%&

I(4$,,9&)*5'*.;&

2$);*9%&

**

* *2FJKJ& CFL0&

2K:CMNJ&

&

O.*6$*%&'()$)-,,)1,%%$)-&

D(

6(

5$4,&

O*.%(()9$A;&,%%$%

5*)5$*@#<-*5&

&

O7

P&/&7

D:&

C(.-3(*;*.&M)B(Q1#)5&I(4$,9*&"#$%?*%5$)-& !(*-,);*9$A;"*$<%@

*9*$<*F1*)@,,.&?*.?(*.*

R.@,)$%6*&P$@9$(5"**;&

E*."#$%<$*)%5&

O,.,6*<$4$&0*3$)%3(.-&

H#$%,.5%&

7,)-*1,%5*&'(

()?(.6*)&

!HRMI&

LKIMDKJ!MKK:&

0KKJ&

MJ!KJIMKS&

:F+77:&

2FFJCFL0CFJK&

PFEKJ:F+77:&

LK0MFJ77:&R.@,)$%6**

0*6**)%4",1%4*)5.,&E*.*)$-$)-*)&

I(4$,,9&?*.?(*.&

O*. % (

)*),9 ,

. 6% T

% 5 **6

&

E9,,6%/B*<*.,,9&

CFL0+JFFOORJ!&O.*?*)5$*&

8*9<1#)5&M)B(.6,5$*&

G(U.<$),5$*&

L*-*9-*?$)-&%,6*)"#$3*)&

O.*6$*%&

H#916$<<* 9*)Q3(.- &(1 &,B%5,)<QMG! &G (

) 5$ )#V

6& ?,)

&'()

*)&

"

'Care Innovation' living lab: Purpose

 Facilitating the innovation of new care and aid processes in elderly care

 Facilitating the innovation of new care and aid products in elderly care


"

'Care Innovation' living lab: Basic principles

 Affordability and socialisation of care and service provision

 Increasing the quality, the performance, the fairness, the relevance and the accessibility of care and service provision

"Care innovation focus

 An integrated approach to society, technology, economy, care providers and local authorities in innovation

 Translation of fundamental research into applied developments and targeted research in care.


"

Care innovation focus

 Creation of a partly open innovation ecosystem

 Development of partnerships

 Active involvement of users in concept, development, research and evaluation throughout the innovation process (co-creation)


"Care innovation living labs

-   A structured test environment for innovative technologies, products, services and concepts.

-   Representative group of individuals in their own living and working environment.

-   Aim: to adjust and/or accelerate innovation and/or to identify future needs.


"Means: care innovation living labs

-   The living lab: one or more living lab platforms -   A platform consists of an infrastructure, a support structure

for the general operation and a test population. -   Already upon their submission, the platforms must be

accompanied by a portfolio of projects which allow the launch of the platform.

-   However, there should still be room for the implementation of additional projects on the platform in the future.



 Integrated, cooperative consortia  Territorial definition  Sufficient degree of diversity in care facilities, service

provision, test population (users and informal carers), spatial planning, housing situation, ...

 Spearhead approach: complementarity and exchangeability of living labs



-   The living lab has an economic and/or social finality.

-   In the social field, attention will be devoted to both keeping the care system affordable and providing a reliable care quality



 Three calls spread over two phases.

  First phase (2012): launch of two calls: - call for living lab platforms + corresponding projects (appropriated budget: € 6.02 M) - call for knowledge gathering project (selection of the scientific consortium (appropriated budget: € 0.93 M).

  Second phase (2013): launch of a supplementary call (appropriated budget: € 2 M), including the possibility for new applicants who wish to use a supported platform, to submit a project proposal.


"

Means: care innovation living labs

  For the platform and project proposals, the applying consortia may be composed of cities and municipalities, companies and social profit organisations with activities that are relevant for the care sector.

 The entire care and value chain (e.g. first line, second line, hospitals, local administrations, housing companies, end users, care economic actors, government, ...)

 The applying consortium of a platform application must at least contain a company and a city or municipality.



  Multidisciplinary, cross-sectoral and transmural cooperation are important conditions

  Guarantee sufficient scale for the living lab to be able to realise an impact on society in the long term

  The consortium has to create a steering group/user committee, which will be composed of cities and municipalities, companies, (transsectoral) care providers, care users and informal carers.
